| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
| mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-06 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |